Clinicopathologic Features and Early Surgical Outcome of Astrocytomas in Eldoret, Kenya

被引:3
作者
Mwita, Clifford C. [1 ,5 ]
Koech, Florentius [1 ]
Sisenda, Titus [1 ]
Patel, Kirtika [2 ]
Macharia, Benson [3 ]
Rahangdale, Devendra [4 ]
机构
[1] Moi Univ, Sch Med, Dept Surg & Anesthesiol, POB 4606-30100, Eldoret, Kenya
[2] Moi Univ, Sch Med, Dept Immunol, Eldoret, Kenya
[3] Moi Univ, Sch Med, Dept Pathol & Forens Med, Eldoret, Kenya
[4] Mediheal Hosp, Dept Radiol, Eldoret, Kenya
[5] Afya Res Africa, Nairobi, Kenya
关键词
Astrocytoma; brain neoplasms; glioblastoma; Ki67;
D O I
10.4103/jnrp.jnrp_562_17
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Astrocytomas are primary central nervous system tumors arising from astrocytes and accounting for up to 37.8% of all brain tumors seen in hospital-based studies from Africa. Despite being common, their patterns and short-term outcomes remain poorly studied in Kenya. Materials and Methods: A prospective, descriptive study involving consecutive patients with a histological diagnosis of astrocytoma seen in three hospitals located in Eldoret, Kenya. Clinicopathologic characteristics and outcomes were recorded and patients followed up for 12 weeks. Results: Thirty-one patients were recruited over a 1-year period. Majority of them were female (51.6%). Headache (83.9%) and focal neurological deficits (64.5%) were the most common presenting features. Among patients with high-grade tumors, mean duration of illness was 106.03 +/- 162.16 days, median functional status was Karnofsky performance status (KPS) score 50, mean tumor size was 110.22 +/- 46.16 cm(3), and median magnetic resonance imaging (MRI) score was 17. Among patients with low-grade astrocytomas, mean duration of illness was 213.03 +/- 344.93 days, median functional status was KPS score 40, mean tumor size was 53.49 +/- 54.96 cm(3) and median MRI score was 9. Glioblastoma multiforme (GBM) (71%) and diffuse astrocytoma (22.6%) were the predominant histological subtypes. The median Ki-67 proliferative index was 6% for pilocytic astrocytoma, 1.6% for diffuse astrocytoma, and 60% for GBM. Systemic and regional surgical complications occurred in 6.5% and 38.7% of patients, respectively. In-hospital mortality was 19.4% and increased to 25.8% at 12 weeks. The KPS score at discharge was 50 and improved to 60 at 12 weeks. Only 9.7% of patients had acceptable functional status at 12 weeks follow-up. Conclusions: In this locality, headache, focal neurological deficits, and reduced functional status are the most common presenting features of astrocytomas while GBM is the most common histological subtype. Tumors are highly proliferative and in the short-term, both surgical and functional outcome are suboptimal.
引用
收藏
页码:363 / 369
页数:7
相关论文
共 22 条
  • [1] Treatment outcome and prognostic factors of adult glioblastoma multiforme
    Ahmadloo, Niloofar
    Kani, Amir-Abbas
    Mohammadianpanah, Mohammad
    Nasrolahi, Hamid
    Omidvari, Shapour
    Mosalaei, Ahmad
    Ansari, Mansour
    [J]. JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (01) : 21 - 30
  • [2] Practical value of MIB-1 index in predicting behavior of astrocytomas
    Ambroise, M. Moses
    Khosla, Charu
    Ghosh, Mitra
    Mallikarjuna, V. S.
    Annapurneswari, S.
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (03) : 520 - 525
  • [3] CBTRUS, 2012, CBTRUS STAT REP PRIM
  • [4] Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection Clinical article
    Chaichana, Kaisorn L.
    Halthore, Aditya N.
    Parker, Scott L.
    Olivi, Alessandro
    Weingart, Jon D.
    Brem, Henry
    Quinones-Hinojosa, Alfredo
    [J]. JOURNAL OF NEUROSURGERY, 2011, 114 (03) : 604 - 612
  • [5] Medical progress: Brain tumors
    DeAngelis, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) : 114 - 123
  • [6] Epidemiology of brain tumors
    Fisher, James L.
    Schwartzbaum, Judith A.
    Wrensch, Margaret
    Wiemels, Joseph L.
    [J]. NEUROLOGIC CLINICS, 2007, 25 (04) : 867 - +
  • [7] Patterns of care and outcome for patients with glioblastoma diagnosed during 20082010 in Spain
    Graus, Francesc
    Bruna, Jordi
    Pardo, Javier
    Escudero, Domingo
    Vilas, Dolores
    Barcelo, Ines
    Brell, Marta
    Pascual, Carmen
    Crespo, Jose A.
    Erro, Elena
    Garcia-Romero, Juan C.
    Estela, Jordi
    Martino, Juan
    Garcia-Castano, Almudena
    Mata, Elena
    Lema, Manuela
    Gelabert, Miguel
    Fuentes, Rafel
    Perez, Pedro
    Manzano, Arancha
    Aguas, Jesus
    Belenguer, Antonio
    Simon, Ana
    Henriquez, Ivan
    Murcia, Mauricio
    Vivanco, Rosa
    Rojas-Marcos, Inigo
    Munoz-Carmona, David
    Navas, Inmaculada
    de Andres, Pablo
    Mas, Gemma
    Gil, Miguel
    Verger, Eugenia
    [J]. NEURO-ONCOLOGY, 2013, 15 (06) : 797 - 805
  • [8] Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas
    Hsu, DW
    Louis, DN
    Efird, JT
    HedleyWhyte, ET
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (08) : 857 - 865
  • [9] Postoperative Deterioration in Health Related Quality of Life as Predictor for Survival in Patients with Glioblastoma: A Prospective Study
    Jakola, Asgeir S.
    Gulati, Sasha
    Weber, Clemens
    Unsgard, Geirmund
    Solheim, Ole
    [J]. PLOS ONE, 2011, 6 (12):
  • [10] Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution Clinical article
    Marina, Ovidiu
    Suh, John H.
    Reddy, Chandana A.
    Barnett, Gene H.
    Vogelbaum, Michael A.
    Peereboom, David M.
    Stevens, Glen H. J.
    Elinzano, Heinrich
    Chao, Samuel T.
    [J]. JOURNAL OF NEUROSURGERY, 2011, 115 (02) : 220 - 229